07:16 EST Bristol Myers (BMY) sees 2026 WW revenue growth of Eliquis 10%-15%
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers reports Q4 adjusted EPS $1.26, consensus $1.20
- Bristol Myers sees FY26 adjusted EPS $6.05-$6.35, consensus $6.04
- Options Volatility and Implied Earnings Moves Today, February 05, 2026
- These Are the Stocks Reporting Earnings Today – February 5, 2026
- Notable companies reporting before tomorrow’s open